Encompass Compliance Corp. (ENCC)

[Avoid]

$ENCC Drug Screening Industry to Grow on Heels of Rising THC, Opioid and Other Recreational Drug Use

April 4, 2017 News Tags: ENCC, ENCC News, Encompass Compliance Corp., Encompass Compliance Corp. News, GreenGro Technologies Inc., GreenGro Technologies Inc. News, GRNH, GRNH News, MYDX, MyDx Inc., MyDx Inc. News, MYDX News, Terra Tech Corp., Terra Tech Corp. News, TRTC, TRTC News
PALM BEACH, Florida, April 4, 2017 /PRNewswire/ --

MarketNewsUpdates.com News Commentary

In a recent article covering the Drug Screening Market, key factors responsible for the growth of the drug and alcohol testing industry are growing based on rising drug and alcohol abuse, along with increased funding by the U.S. Federal Governments for drug testing for THC, Opioids, alcohol and other recreational/addictive drug use. Furthermore, growing awareness on drug screening procedures across developing nations is a major factor boosting the market growth. Developments in the cannabis and drug screen industries alike for emerging companies include: Encompass Compliance Corp. (OTC: ENCC) and for some level cannabis operations companies: MyDx, Inc. (OTC: MYDX), 22nd Century Group, Inc. (NYSE: XXII), GreenGro Technologies, Inc. (OTC: GRNH), Terra Tech Corp. (OTC: TRTC).

Encompass Compliance Corp. (OTC: ENCC) Encompass Compliance Corp. has compiled critical data of the savings, by a fortune 500 Customer that has over 100,000 employees in the U.S. This respective company conducted a 6-state pilot implementing Encompass Compliance Corporation's Risk Shield services and "the results were amazing," the customer said. After just 6 months, the company's drug and alcohol claims were reduced by 20%, resulting in a $6.5 million savings on claim pay outs. The results were so impressive, they have decided to expand the program to more states. This was a post-accident only pilot testing for some key drugs such as: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine and ecstasy. "Compliance is key, but in addition to compliance you must aggressively pursue the benefits that exist for employers which can only be accomplished if state rules are followed. Helping our customers follow the rules is what we do," says Encompass Co-Founder and CRO, Bill Judge. Read this and more news for ENCC at: http://marketnewsupdates.com/news/encc.html

Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our Risk Shield solution provides organizations with up-to-date policies, a comprehensive resource center and real-time monitoring for drug and alcohol testing orders.

In other cannabis industry news or market performances of note:

MyDx, Inc. (OTCQB: MYDX) closed up over 12% on Monday trading over 71.5 Million shares by the market close. MyDx, Inc. is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust and Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user's hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest.

22nd Century Group, Inc. (NYSE: XXII) closed up over 4% on Monday at $1.23 trading over 1.2 Million shares by the market close. 22nd Century Group, Inc., a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced last week that leading scientists published more than 12 new studies involving 22nd Century's Very Low Nicotine (VLN) cigarettes at the 23rd Annual Meeting of the Society for Research on Nicotine & Tobacco (SRNT) held earlier this month in Florence, Italy. The event was attended by leading tobacco scientists and public health officials from around the world, including acclaimed university scientists, representatives from the FDA and other regulatory agencies, and tobacco industry executives.

GreenGro Technologies, Inc. (OTC: GRNH) closed up over 7% on Monday at $0.0665 trading over 5 Million shares by the market close. Greengro Technologies, Inc., a world-class provider of eco-friendly green technologies, late last week announced it has received a $600,000 down payment on a $7.4 million flagship three-acre turnkey off-grid PV-solar glass greenhouse from Fresh Local Produce of Ohio, an indoor hydroponic farming company based in Akron, Ohio. The companies expect to be breaking ground on the new facility in the third quarter of 2017.

Terra Tech Corp. (OTCQX: TRTC) close up over 5% on Monday at $0.291 trading over 9.5 Million shares by the market close. Terra Tech Corp., a vertically integrated cannabis-focused agriculture company, on this past Friday announced its financial results for the year ending December 31, 2016. See the full financial report at http://finance.yahoo.com/news/terra-tech-corp-reports-record-202500429.html

SOURCE MarketNewsUpdates.com

https://www.otcdynamics.com/encc-drug-screening-industry-to-grow-on-heels-of-rising-thc-opioid-and-other-recreational-drug-use/?utm_campaign=twitter&utm_medium=twitter&utm_source=twitter